FITC
Based on 92 publication(s) in Google Scholar
FITC (Fluorescein Isothiocyanate), is one of the green fluorescein derivatives widely used in biology. FITC has the characteristics of high absorptivity and excellent fluorescence quantum yield. The isothiocyanate group of FITC can be combined with amino, sulfhydryl, imidazole, tyrosyl, carbonyl and other groups on the protein, so as to achieve protein labeling including antibodies and lectins. In addition to its use as a protein marker, FITC can also be used as a fluorescent protein tracer to rapidly identify pathogens by labeling antibodies, or for microsequencing of proteins and peptides (HPLC). The maximum excitation wavelength of FITC is 494 nm. Once excited, it fluoresces yellow-green at a maximum emission wavelength of 520 nm. In addition, FITC is also a hapten that can induce contact hypersensitivity (CHS) and induce an atopic dermatitis model.
For research use only. We do not sell to patients.
- Purity: 98.60%
- CAS No.: 3326-32-7
- Formula: C21H11NO5S
- Molecular Weight:389.38
-
Storage:
-20°C, protect from light, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
Publications Citing Use of MedChemExpress (MCE) FITC
More- Adv Mater. 2025 Sep;37(35):e2500631. [Abstract]
- Adv Mater. 2025 Apr 30:e2501137. [Abstract]
- Adv Mater. 2024 May;36(19):e2313248. [Abstract]
- Adv Mater. 2023 Nov;35(48):e2306469. [Abstract]
- Sci Bull. 2023 Jan 15;68(1):77-94. [Abstract]
- Adv Funct Mater. 2024 Feb 8.
- Cell Host Microbe. 2025 Aug 19:S1931-3128(25)00291-4. [Abstract]
- ACS Nano. 2023 Jul 25;17(14):13917-13937. [Abstract]
- ACS Nano. 2022 Oct 25;16(10):15959-15976. [Abstract]
- ACS Nano. 2021 Oct 26;15(10):16286-16297. [Abstract]
- ACS Nano. 2020 Nov 24;14(11):14907-14918. [Abstract]
- Nat Commun. 2021 Nov 5;12(1):6426. [Abstract]
- Acta Pharm Sin B. 2025 Aug;15(8):4265-4284. [Abstract]
- Acta Pharm Sin B. 2025 May;15(5):2703-2722. [Abstract]
- Acta Pharm Sin B. 2023 Feb;13(2):852-862. [Abstract]
- Autophagy. 2023 Feb;19(2):616-631. [Abstract]
- Compos B Eng. 2024 Jul 15.
- Adv Sci (Weinh). 2025 Nov 21:e10500. [Abstract]
- Adv Sci (Weinh). 2025 Sep 26:e02395. [Abstract]
- Adv Sci (Weinh). 2022 Mar;9(8):e2104344. [Abstract]
- Chem Eng J. 2026 Feb 16.
- Chem Eng J. 2026 Jan 9;529:172756.
- Chem Eng J. 2024 May 1, 487, 150501.
- Chem Eng J. 2020, 127870.
- Biomaterials. 2025 May 5:322:123391. [Abstract]
- Biomaterials. 2025 Jan:312:122742. [Abstract]
- J Nanobiotechnology. 2025 Feb 21;23(1):131. [Abstract]
- J Nanobiotechnology. 2024 Nov 21;22(1):725. [Abstract]
- J Nanobiotechnology. 2023 Nov 14;21(1):424. [Abstract]
- J Nanobiotechnology. 2022 Feb 2;20(1):61. [Abstract]
- J Nanobiotechnology. 2021 May 26;19(1):156. [Abstract]
- Carbohydr Polym. 2021 Aug 1:265:118064. [Abstract]
- Small. 2025 Mar 16:e2412815. [Abstract]
- Small. 2022 Jul;18(30):e2202337. [Abstract]
- J Control Release. 2024 Dec 31:378:864-879. [Abstract]
- Cell Rep Med. 2026 Mar 17;7(3):102635. [Abstract]
- J Immunother Cancer. 2025 Feb 6;13(2):e010150. [Abstract]
- Mater Today Bio. 2025 Mar 27:32:101712. [Abstract]
- Adv Healthc Mater. 2026 Feb 21:e05684. [Abstract]
- Int J Biol Macromol. 2025 Aug;319(Pt 1):145389. [Abstract]
- Int J Biol Macromol. 2025 Apr 13;309(Pt 4):143143. [Abstract]
- Int J Biol Macromol. 2024 Nov;281(Pt 1):136064. [Abstract]
- Int J Biol Macromol. 2024 Apr 20;268(Pt 1):131723. [Abstract]
- Int J Biol Macromol. 2024 Feb;257(Pt 2):128695. [Abstract]
- Phytomedicine. 2024 May 14:130:155737. [Abstract]
- Food Chem X. 2026 Jan 5:33:103479. [Abstract]
- ACS Appl Mater Interfaces. 2025 Dec 21. [Abstract]
- ACS Appl Mater Interfaces. 2025 Aug 6;17(31):44249-44262. [Abstract]
- ACS Appl Mater Interfaces. 2025 Mar 28. [Abstract]
- ACS Appl Mater Interfaces. 2024 Nov 6;16(44):59921-59933. [Abstract]
- ACS Appl Mater Interfaces. 2024 Sep 25;16(38):50212-50228. [Abstract]
- Cancer Immunol Res. 2024 Jun 4;12(6):744-758. [Abstract]
- ACS Appl Mater Interfaces. 2022 Aug 10;14(31):36132-36142. [Abstract]
- Mater Sci Eng C Mater Biol Appl. 2020 Nov;116:111244. [Abstract]
- Food Res Int. 2026 Jun 1;233(Pt 2):119022. [Abstract]
- Food Res Int. 2026 Apr 1:229:118488. [Abstract]
- Biofabrication. 2025 Oct 24. [Abstract]
- Food Res Int. 2025 Dec;221(Pt 4):117521. [Abstract]
- Mater Des. 2025 Aug 20.
- NPJ Sci Food. 2025 Oct 31;9(1):215. [Abstract]
- Stem Cell Res Ther. 2025 Jun 20;16(1):316. [Abstract]
- Chem Mater. 2023 Apr 4.
- Cell Rep. 2025 Dec 10;44(12):116673. [Abstract]
- Anal Chem. 2025 Apr 8. [Abstract]
- Anal Chem. 2025 Jan 14;97(1):247-254. [Abstract]
- Int J Nanomedicine. 2025 Dec 2:20:14329-14341. [Abstract]
- J Anim Sci Biotechnol. 2023 Dec 20;14(1):157. [Abstract]
- J Agric Food Chem. 2025 Jun 4;73(22):13295-13312. [Abstract]
- Ind Crops Prod. 1 December 2022, 115746.
- Polym Test. 2023 Dec 1, 108292.
- J Mater Chem B. 2024 Nov 6;12(43):11237-11250. [Abstract]
- J Ethnopharmacol. 2026 May 23:363:121417. [Abstract]
- Biomacromolecules. 2025 Oct 16. [Abstract]
- J Ethnopharmacol. 2023 Apr 6:305:116093. [Abstract]
- Foods. 2024 Apr 1;13(7):1076. [Abstract]
- Int J Mol Sci. 2022 Aug 12;23(16):9049. [Abstract]
- Invest Ophthalmol Vis Sci. 2026 Jan 5;67(1):21. [Abstract]
- Mater Adv. 2025 Sep 21;6(18):6394-6405. [Abstract]
- RSC Adv. 2026 Jan 5;16(2):1078-1094. [Abstract]
- Eur J Pharm Biopharm. 2023 Aug:189:152-164. [Abstract]
- Poult Sci. 2025 Dec;104(12):105918. [Abstract]
- Tissue Eng Regen Med. 2026 Feb;23(2):329-342. [Abstract]
- Brain Res Bull. 2025 Sep:229:111479. [Abstract]
- Vet Res. 2025 Feb 7;56(1):33. [Abstract]
- Mol Med Rep. 2019 Jan;19(1):41-50. [Abstract]
- J Phys D Appl Phys. 2025 Nov 13.
- Mol Immunol. 2023 Oct:162:84-94. [Abstract]
- Neurogastroenterol Motil. 2025 May 20:e70066. [Abstract]
- Int J Dairy Technol. 2025 Oct 22;78(4):e70070.
- Res Sq. 2024 Nov 10.
- Research Square Preprint. 2023 Jul 12.
- Patent. US20210223256A1.
-
Others
-
IF
-
IF
-
IF
-
IF
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| L1210 | IC50 |
700 μM
Compound: FITC
|
Cytotoxicity against mouse L1210 cells after 24 hrs by WST8 assay
Cytotoxicity against mouse L1210 cells after 24 hrs by WST8 assay
|
[PMID: 18951028] |
Guide (The following is our recommended protocol. This protocol is only a guide and should be modified according to your specific needs).
1. Protein Preparation
To obtain the best labeling effect, please prepare the protein (antibody) concentration to 1 mg/mL.
1.1 The pH value of the protein solution should be 8.5 ± 0.5. If the pH is lower than 8.0, adjust it with 1 M sodium bicarbonate.
1.2 If the protein concentration is lower than 1 mg/mL, the labeling efficiency will be greatly reduced. To obtain the best labeling efficiency, it is recommended that the final protein concentration range be 1-10 mg/mL.
1.3 The protein must be in a buffer free of primary amines (such as Tris or glycine) and ammonium ions, otherwise the labeling efficiency will be affected.
2.Dye Preparation
Add anhydrous DMSO into the vial of FITC to make a 1 mg/mL stock solution. Mix well by pipetting or vortex.
3.Calculation of dye dosage
The amount of FITC required for reaction depends on the amount of protein to be labeled, and the optimal molar ratio of FITC to protein is about 10.
Example: assuming the required marker protein is 1 mL 2 mg/mL IgG (MW=150,000), use 1 mL DMSO dissolve 1 mg FITC, the required FITC volume is 40 μL.
4. Running the Coupling Reaction
1) Slowly add the calculated volume of freshly prepared 10 mg/mL dye to 0.5 mL of protein sample solution, gently shake to mix, and then briefly centrifuge to collect the sample at the bottom of the reaction tube. Avoid vigorous mixing to prevent denaturation and inactivation of the protein sample.
2) Place the reaction tube in a dark place and incubate gently with shaking for 60 minutes at room temperature. Every 10-15 minutes, gently invert the reaction tube several times to thoroughly mix the reactants and improve labeling efficiency.
5. Purification of Conjugates
The following protocol is an example of purifying dye-protein conjugates using a Labelling Kits Centrifugation-Based Rapid Desalting Column (5KD) (HY-D3014).
5.1 Prepare the desalting column according to the instructions.
5.2 Load the reaction mixture onto the top of the desalting column.
5.3 Once the sample has run below the resin surface, immediately add PBS (pH 7.2-7.4).
5.4 Add more PBS (pH 7.2-7.4) to the target sample to complete column purification. Collect the fraction containing the desired dye-protein conjugate.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
525
488
Chemical Information
-
CAS No. 3326-32-7
-
Appearance Solid
-
Molecular Weight 389.38
-
Formula C21H11NO5S
-
Color Light yellow to orange
-
SMILES
O=C1OC2(C3=C(OC4=C2C=CC(O)=C4)C=C(O)C=C3)C5=C1C=C(N=C=S)C=C5
-
Synonyms
Fluorescein 5-isothiocyanate
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
-20°C, protect from light, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
Publications (92)
-
Journal Impact Factor
-
Most Recent
-
Adv Mater
Fueling IgA-Dominated Humoral Immunity with an Intranasal Hybrid Tumor Vaccine to Opsonize and Strike Epithelial Breast Cancer. [Abstract]2025 Sep;37(35):e2500631. PMID: 40589412 -
Adv Mater
Zwitterionic Brush-Grafted Interfacial Bio-Lubricant Evades Complement C3-Mediated Macrophage Phagocytosis for Osteoarthritis Therapy. [Abstract]2025 Apr 30:e2501137. PMID: 40304130 -
Adv Mater
Catalytic Nanodots-Driven Pyroptosis Suppression in Nucleus Pulposus for Antioxidant Intervention of Intervertebral Disc Degeneration. [Abstract]2024 May;36(19):e2313248. PMID: 38299823 -
Adv Mater
2023 Nov;35(48):e2306469. PMID: 37669827 -
Sci Bull
Topology regulation of nanomedicine for autophagy-augmented ferroptosis and cancer immunotherapy. [Abstract]2023 Jan 15;68(1):77-94. PMID: 36621435 -
-
Cell Host Microbe
2025 Aug 19:S1931-3128(25)00291-4. PMID: 40848719 -
ACS Nano
A Dual-Targeted Metal-Organic Framework Based Nanoplatform for the Treatment of Rheumatoid Arthritis by Restoring the Macrophage Niche. [Abstract]2023 Jul 25;17(14):13917-13937. PMID: 37429012 -
ACS Nano
Living Macrophage-Delivered Tetrapod PdH Nanoenzyme for Targeted Atherosclerosis Management by ROS Scavenging, Hydrogen Anti-inflammation, and Autophagy Activation. [Abstract]2022 Oct 25;16(10):15959-15976. PMID: 36219731 -
ACS Nano
Endogenous Copper for Nanocatalytic Oxidative Damage and Self-Protection Pathway Breakage of Cancer. [Abstract]2021 Oct 26;15(10):16286-16297. PMID: 34652919 -
ACS Nano
Tumor Vessel Targeted Self-Assemble Nanoparticles for Amplification and Prediction of the Embolization Effect in Hepatocellular Carcinoma. [Abstract]2020 Nov 24;14(11):14907-14918. PMID: 33111520
FITC purchased from MedChemExpress. Usage Cited in: ACS Nano. 2020 Nov 24;14(11):14907-14918. [Abstract]
FITC-labeled MnO2/BPD are added at a concentration of 50 μg/mL and incubated for another 4 h to allow the nanoparticles to enter the cells. By conjugating FITC to MnO2/BPD, FL could be monitored at 488 nm, and the vessels could be observed at 660 nm by Evans Blue staining.
-
Nat Commun
Arabidopsis P4 ATPase-mediated cell detoxification confers resistance to Fusarium graminearum and Verticillium dahliae. [Abstract]2021 Nov 5;12(1):6426. PMID: 34741039
FITC purchased from MedChemExpress. Usage Cited in: Nat Commun. 2021 Nov 5;12(1):6426. [Abstract]
Cinnamate acetate (CIA) was labeled with FITC. Distribution of CIA/FITC in root cells of wild-type, ala7 mutant and complemented Arabidopsis seedlings. The seedlings were treated with CIA/FITC (5 μg/mL) and FM4-64 (8 μM) for 1 h, 2 h, and 8 h.
-
Acta Pharm Sin B
Unveiling the renoprotective mechanisms of self-assembled herbal nanoparticles from Scutellaria barbata and Scleromitrion diffusum in acute kidney injury: A nano-TCM approach. [Abstract]2025 Aug;15(8):4265-4284. PMID: 40893687 -
Acta Pharm Sin B
A cisplatin prodrug-based self-assembling ozone delivery nanosystem sensitizes radiotherapy in triple-negative breast cancer. [Abstract]2025 May;15(5):2703-2722. PMID: 40487662 -
Acta Pharm Sin B
Precise assembly of inside-out cell membrane camouflaged nanoparticles via bioorthogonal reactions for improving drug leads capturing. [Abstract]2023 Feb;13(2):852-862. PMID: 36873174 -
Autophagy
A plant nonenveloped double-stranded RNA virus activates and co-opts BNIP3-mediated mitophagy to promote persistent infection in its insect vector. [Abstract]2023 Feb;19(2):616-631. PMID: 35722949 -
-
Adv Sci (Weinh)
Targeting the SOX9/TIMP1 Axis with iRGD-Conjugated Nanoplatform Enhances Dendritic Cell Function and Photodynamic Immunotherapy in Gastric Cancer. [Abstract]2025 Nov 21:e10500. PMID: 41270217 -
Adv Sci (Weinh)
Calhm6 Governs Macrophage Polarization Through Chp1-Camk4-Creb1 Axis and Ectosomal Delivery in Inflammatory Responses. [Abstract]2025 Sep 26:e02395. PMID: 40999918 -
Adv Sci (Weinh)
A Selective Small-Molecule c-Myc Degrader Potently Regresses Lethal c-Myc Overexpressing Tumors. [Abstract]2022 Mar;9(8):e2104344. PMID: 35048559
FITC purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2022 Mar;9(8):e2104344. [Abstract]
For detection of localization of WBC100 in cells, FITC labeled WBC100 (WBC100‐FITC) is used. HEK293T cells are transfected with the indicated plasmids for 48 h. Cells are treated with 1 μM WBC100‐FITC or FITC for 24 h.
-
-
-
-
FITC purchased from MedChemExpress. Usage Cited in: Chem Eng J. 2020, 127870.
FITC (1 mg/mL) solution was prepared with dimethyl sulfoxide. Then FITC solution was added dropwise into laccase (5 mg/mL) solution, and the mixed solution was stirred at 4 °C for 4 h. Laccase was labelled by FITC and exhibited green emissions.
-
Biomaterials
Radiation-triggerable bioreactors enable bioenergetic reprograming of cancer stem cell plasticity via targeted arginine metabolism disruption for augmented radio-immunotherapy. [Abstract]2025 May 5:322:123391. PMID: 40344881
FITC purchased from MedChemExpress. Usage Cited in: Biomaterials. 2025 May 5:322:123391. [Abstract]
Design and construction of RTBs for remodeling CSC plasticity. Fluorescence emission spectra of FITC-RTB-RhB at 488 nm. (FITC: HY-66019; RhB, Rhodamine B, HY-Y0016)
-
Biomaterials
Single-dose of integrated bilayer microneedles for enhanced hypertrophic scar therapy with rapid anti-inflammatory and sustained inhibition of myofibroblasts. [Abstract]2025 Jan:312:122742. PMID: 39106821 -
J Nanobiotechnology
Metal-organic framework nanoparticles activate cGAS-STING pathway to improve radiotherapy sensitivity. [Abstract]2025 Feb 21;23(1):131. PMID: 39979917 -
J Nanobiotechnology
High-throughput screening-based design of multifunctional natural polyphenol nano-vesicles to accelerate diabetic wound healing. [Abstract]2024 Nov 21;22(1):725. PMID: 39574119 -
J Nanobiotechnology
A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response. [Abstract]2023 Nov 14;21(1):424. PMID: 37964304 -
J Nanobiotechnology
Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy. [Abstract]2022 Feb 2;20(1):61. PMID: 35109867
FITC purchased from MedChemExpress. Usage Cited in: J Nanobiotechnology. 2022 Feb 2;20(1):61. [Abstract]
To exam the ability of anti-PD-L1 antibodies (aPD-L1) nanovesicles to binding to tumor cells, B16F10 cells are cultured for 24 h. FITC-labeled aPD-L1 nanovesicles or nanovesicles are incubated with the cancer cells for 3 h.
-
J Nanobiotechnology
2021 May 26;19(1):156. PMID: 34039349 -
Carbohydr Polym
2021 Aug 1:265:118064. PMID: 33966828 -
Small
Ultrasound-Driven Piezoelectric Heterostructures Block Early Atherosclerotic Plaques Progression. [Abstract]2025 Mar 16:e2412815. PMID: 40091396 -
Small
DNA Base Pairing-Inspired Supramolecular Nanodrug Camouflaged by Cancer-Cell Membrane for Osteosarcoma Treatment. [Abstract]2022 Jul;18(30):e2202337. PMID: 35780479 -
J Control Release
2024 Dec 31:378:864-879. PMID: 39740695 -
Cell Rep Med
Enhancing gastric cancer immunotherapy: Insights from multi-omics analysis and innovations in photodynamic-chemotherapy nanoplatforms. [Abstract]2026 Mar 17;7(3):102635. PMID: 41747719 -
J Immunother Cancer
Reinforcing cancer immunotherapy with engineered porous hollow mycobacterium tuberculosis loaded with tumor neoantigens. [Abstract]2025 Feb 6;13(2):e010150. PMID: 39915006 -
Mater Today Bio
Metal-organic framework-based delivery systems as nanovaccine for enhancing immunity against porcine circovirus type 2. [Abstract]2025 Mar 27:32:101712. PMID: 40230641 -
Adv Healthc Mater
An Injectable Liposome-Hydrogel Composite for Targeted Delivery of a Non-Lactylated Peptide to Rebalance Bone Metabolism in Hyperlipidemia. [Abstract]2026 Feb 21:e05684. PMID: 41721628 -
Int J Biol Macromol
Engineering a phosphatidylserine-targeting drug carrier based on lactadherin C2 domain fused with human serum albumin for tumor therapy. [Abstract]2025 Aug;319(Pt 1):145389. PMID: 40543781 -
Int J Biol Macromol
Hyaluronic acid-modified PtPdCo-CQ nanocatalyst with triple enzyme-like activities regulates macrophage polarization and autophagy levels for the treatment of rheumatoid arthritis. [Abstract]2025 Apr 13;309(Pt 4):143143. PMID: 40233904 -
Int J Biol Macromol
Recombinant filaggrin-2 improves skin barrier function and attenuates ultraviolet B (UVB) irradiation-induced epidermal barrier disruption. [Abstract]2024 Nov;281(Pt 1):136064. PMID: 39341309 -
Int J Biol Macromol
An endometrial biomimetic extracellular matrix (ECM) for enhanced endometrial regeneration using hyaluronic acid hydrogel containing recombinant human type III collagen. [Abstract]2024 Apr 20;268(Pt 1):131723. PMID: 38649072 -
Int J Biol Macromol
Management of non-compressible hemorrhage and re-bleeding by a liquid hemostatic polysaccharide floccuronic acid. [Abstract]2024 Feb;257(Pt 2):128695. PMID: 38072343 -
Phytomedicine
A facile fluorescence-coupling approach to visualizing leonurine uptake and distribution in living cells and Caenorhabditis elegans. [Abstract]2024 May 14:130:155737. PMID: 38772183 -
Food Chem X
The influence mechanism of continuous hot-air drying on the nutritional, microstructure and in-vitro digestibility properties of protein and starch in whole-grain glutinous corn (black pearl) flour. [Abstract]2026 Jan 5:33:103479. PMID: 41585550 -
ACS Appl Mater Interfaces
Biological Nanocarrier-Based Therapy for Breast Cancer Using Modified Faecalibaculum rodentium-Derived Bacterial Membrane Vesicles. [Abstract]2025 Dec 21. PMID: 41423854 -
ACS Appl Mater Interfaces
Self-Assembled Nanobody-Albumin Platform with Dye Encapsulation for NIR-II Imaging-Guided Photodynamic Therapy. [Abstract]2025 Aug 6;17(31):44249-44262. PMID: 40701815 -
ACS Appl Mater Interfaces
Gold Nanoparticles Carrying Mannose-Binding Lectin and Inflammatory Cytokine Antibodies Improve Sepsis Survival by Modulating Immunity and Reducing Pathogens. [Abstract]2025 Mar 28. PMID: 40152885 -
ACS Appl Mater Interfaces
Prolonged Retention of Albumin Nanoparticles Alleviates Renal Ischemia-Reperfusion Injury through Targeted Pyroptosis. [Abstract]2024 Nov 6;16(44):59921-59933. PMID: 39437799 -
ACS Appl Mater Interfaces
Orally Deliverable Microalgal-Based Carrier with Selenium Nanozymes for Alleviation of Inflammatory Bowel Disease. [Abstract]2024 Sep 25;16(38):50212-50228. PMID: 39266250 -
Cancer Immunol Res
The ω-3 polyunsaturated fatty acid docosahexaenoic acid enhances NK-cell antitumor effector functions. [Abstract]2024 Jun 4;12(6):744-758. PMID: 38526128 -
ACS Appl Mater Interfaces
Enhancing the Antifouling Ability of a Polyamide Nanofiltration Membrane by Narrowing the Pore Size Distribution via One-Step Multiple Interfacial Polymerization. [Abstract]2022 Aug 10;14(31):36132-36142. PMID: 35881887 -
Mater Sci Eng C Mater Biol Appl
Precise and tunable time-controlled drug release system using layer-by-layer films as erodible coatings. [Abstract]2020 Nov;116:111244. PMID: 32806253 -
Food Res Int
Orally engineered liver-targeted garlic exosome-like nanovesicles for astaxanthin precise delivery against alcoholic liver disease in mice. [Abstract]2026 Jun 1;233(Pt 2):119022. PMID: 41956676 -
Food Res Int
Charge-governed ionic essential oil-loaded liposomes for enhanced penetration and removal of Listeria monocytogenes biofilms. [Abstract]2026 Apr 1:229:118488. PMID: 41763810 -
Biofabrication
Engineering an organoid culture system for enhanced murine and human hematopoietic stem and progenitor cell self-renewal and expansion. [Abstract]2025 Oct 24. PMID: 41135540 -
Food Res Int
Collagen peptides derived from sea bass scales (Lateolabrax maculatus) relieve photoaging through MAPK, NF-κB and TGF-β signaling pathways and modulating gut microbiota composition. [Abstract]2025 Dec;221(Pt 4):117521. PMID: 41185279 -
-
NPJ Sci Food
Bone-targeted celastrol nanocarrier suppresses osteoclastogenesis in postmenopausal osteoporosis. [Abstract]2025 Oct 31;9(1):215. PMID: 41173888 -
Stem Cell Res Ther
The influence of femtosecond laser intrastromal lenticules on the characteristics and maturity in tissue-engineered stem cell-derived retinal pigment epithelium sheets. [Abstract]2025 Jun 20;16(1):316. PMID: 40542390 -
-
Cell Rep
Aryl hydrocarbon receptor-induced activation of AIM2 inflammasome is mediated by MOMP and MPT: A vital therapeutic pathway for inflammation. [Abstract]2025 Dec 10;44(12):116673. PMID: 41385364 -
Anal Chem
Biomimetic Microparticles with Myocardial and Endocardial Integration for Drug Toxicity Studies. [Abstract]2025 Apr 8. PMID: 40198907 -
Anal Chem
Bioorthogonal Synthesis of Biomimetic Nanoparticles for Screening Chemical Hazards in Food Samples. [Abstract]2025 Jan 14;97(1):247-254. PMID: 39810346 -
Int J Nanomedicine
Os Draconis-Derived Nanoparticles Improve Insomnia Symptoms by Activating Calcium-Dependent 5-HT Release and the Vagal-NTS Pathway. [Abstract]2025 Dec 2:20:14329-14341. PMID: 41368289 -
J Anim Sci Biotechnol
Enterogenic Stenotrophomonas maltophilia migrates to the mammary gland to induce mastitis by activating the calcium-ROS-AMPK-mTOR-autophagy pathway. [Abstract]2023 Dec 20;14(1):157. PMID: 38124149 -
J Agric Food Chem
Chitosan Nanoparticles Encapsulate Antimicrobial Peptides for the Prevention and Control of Citrus reticulata Huanglongbing and Their Distribution in Plants. [Abstract]2025 Jun 4;73(22):13295-13312. PMID: 40403163 -
-
-
J Mater Chem B
2024 Nov 6;12(43):11237-11250. PMID: 39373456 -
J Ethnopharmacol
Simo Tang mitigates mitochondria-dependent apoptosis via PI3K/AKT pathway activation in Chronic atrophic gastritis. [Abstract]2026 May 23:363:121417. PMID: 41765119 -
Biomacromolecules
Engineered Sulfonated Bacterial Cellulose Hydrogel with Dual Bioactive-Drug Delivery Functions for Precision Treatment of Psoriasis. [Abstract]2025 Oct 16. PMID: 41102014 -
J Ethnopharmacol
Prinsepia utilis Royle leaf extract: Ameliorative effects on allergic inflammation and skin lesions in allergic contact dermatitis and polyphenolic profiling through UPLC-MS/MS coupled to chemometric analysis. [Abstract]2023 Apr 6:305:116093. PMID: 36603785 -
Foods
Differences in Biofilm Formation of Listeria monocytogenes and Their Effects on Virulence and Drug Resistance of Different Strains. [Abstract]2024 Apr 1;13(7):1076. PMID: 38611380 -
Int J Mol Sci
Aberrant Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem Cells of a Retinitis Pigmentosa Patient with the PRPF6 Mutation. [Abstract]2022 Aug 12;23(16):9049. PMID: 36012314 -
Invest Ophthalmol Vis Sci
PRPF8 Mutation-Induced Defects in Human iPSC-Derived RPE Are Rescued by Adenine Base Editing. [Abstract]2026 Jan 5;67(1):21. PMID: 41533919 -
Mater Adv
In-Petri-Dish Traveling and Standing Acoustic Wave-Assisted Fabrication of Anisotropic Collagen Hydrogels. [Abstract]2025 Sep 21;6(18):6394-6405. PMID: 41050515 -
RSC Adv
Low-intensity pulsed ultrasound responsive phase-change nanoparticles loaded with rapamycin for targeted therapy of atherosclerotic plaques. [Abstract]2026 Jan 5;16(2):1078-1094. PMID: 41496825 -
Eur J Pharm Biopharm
Cyclosporine A-loaded colon-targeted oral nanomicelles self-assembly by galactosylated carboxymethyl chitosan for efficient ulcerative colitis therapy. [Abstract]2023 Aug:189:152-164. PMID: 37336365 -
Poult Sci
Early life supplementation of Lactobacillus reuteri 21 promotes broiler intestinal proliferation and differentiation through indole-3-carboxaldehyde. [Abstract]2025 Dec;104(12):105918. PMID: 41135471 -
Tissue Eng Regen Med
Bacteriophage Cocktail in Hydrogel Dressing Modulates Macrophage Responses and Induces Skin Cell Migration. [Abstract]2026 Feb;23(2):329-342. PMID: 41518514 -
Brain Res Bull
Sevoflurane reduces brain edema and improves blood-brain barrier by downregulating CaMKII to inhibit TMEM16A after cerebral ischemia injury both in vivo and in vitro. [Abstract]2025 Sep:229:111479. PMID: 40714175 -
Vet Res
The tryptophan-aspartate (WD) repeat domain of bovine Coronin-1A promotes mycobacterial survival by inhibiting calcium signaling-mediated phagosome-lysosome fusion. [Abstract]2025 Feb 7;56(1):33. PMID: 39920838 -
Mol Med Rep
Hyperoside decreases the apoptosis and autophagy rates of osteoblast MC3T3‑E1 cells by regulating TNF‑like weak inducer of apoptosis and the p38mitogen activated protein kinase pathway. [Abstract]2019 Jan;19(1):41-50. PMID: 30387825 -
-
Mol Immunol
D-mannose acts as a V-ATPase inhibitor to suppress inflammatory cytokines generation and bacterial killing in macrophage. [Abstract]2023 Oct:162:84-94. PMID: 37660434 -
Neurogastroenterol Motil
Electroacupuncture Improves Intestinal Ischemia/Reperfusion Injury via cGAS-STING Pathway. [Abstract]2025 May 20:e70066. PMID: 40391398 -
-
-
-
Solvent & Solubility
DMSO : 62.5 mg/mL (160.51 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
Protocol
The frequency of chondrocyte apoptosis is measured by flow cytometry with Annexin V-fluorescein isothiocyanate (FITC) and propidium iodide. A total of 1×104 treated chondrocytes are collected from each group, washed in cold PBS and incubated with Annexin V-FITC and PI at room temperature for 15 min in the dark on ice. These samples are then analyzed using a fluorescence-activated cell sorter. Cell Quest software is used to analyze the percentage of apoptosis. All tests are repeated in triplicate.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
-
Data Sheet (285 KB)
-
SDS (480 KB)
- English - EN (480 KB)
- Français - FR (480 KB)
- Deutsch - DE (480 KB)
- Norwegian - NO (480 KB)
- Español - ES (480 KB)
- Swedish - SV (480 KB)
- Italian - IT (480 KB)
- Portuguese - PT (480 KB)
-
Handling Instructions (2659 KB)
References
[1]. Gao SG, et al. Phosphorylation of osteopontin has proapoptotic and proinflammatory effects on human knee osteoarthritis chondrocytes. Exp Ther Med. 2016 Nov;12(5):3488-3494. Epub 2016 Oct 5. [Content Brief]
[2]. Zhu X, et al. Ratiometric, visual, dual-signal fluorescent sensing and imaging of pH/copper ions in real samples based on carbon dots-fluorescein isothiocyanate composites. Talanta. 2017 Jan 1;162:65-71 [Content Brief]
[3]. Shigeno T, et al. Phthalate ester‐induced thymic stromal lymphopoietin mediates allergic dermatitis in mice[J]. Immunology, 2009, 128(1pt2): e849-e857. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.5682 mL | 12.8409 mL | 25.6819 mL | 64.2046 mL |
| 5 mM | 0.5136 mL | 2.5682 mL | 5.1364 mL | 12.8409 mL | |
| 10 mM | 0.2568 mL | 1.2841 mL | 2.5682 mL | 6.4205 mL | |
| 15 mM | 0.1712 mL | 0.8561 mL | 1.7121 mL | 4.2803 mL | |
| 20 mM | 0.1284 mL | 0.6420 mL | 1.2841 mL | 3.2102 mL | |
| 25 mM | 0.1027 mL | 0.5136 mL | 1.0273 mL | 2.5682 mL | |
| 30 mM | 0.0856 mL | 0.4280 mL | 0.8561 mL | 2.1402 mL | |
| 40 mM | 0.0642 mL | 0.3210 mL | 0.6420 mL | 1.6051 mL | |
| 50 mM | 0.0514 mL | 0.2568 mL | 0.5136 mL | 1.2841 mL | |
| 60 mM | 0.0428 mL | 0.2140 mL | 0.4280 mL | 1.0701 mL | |
| 80 mM | 0.0321 mL | 0.1605 mL | 0.3210 mL | 0.8026 mL | |
| 100 mM | 0.0257 mL | 0.1284 mL | 0.2568 mL | 0.6420 mL |